Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Gastric linitis plastica (gastric LP) is a malignant, diffuse, infiltrative gastric adenocarcinoma.
Biomarker and diagnostic research for gastric linitis plastica has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered. Interventions under study include drug therapy. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
52 publications have been identified in PubMed for gastric linitis plastica. Research spans Case Report / Case Series (37%), Clinical Trial Publication (25%), and Diagnostic / Biomarker (21%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 19 | 37% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 3:00 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Clinical study results |
13 |
25% |
Testing and diagnosis research | 11 | 21% |
Research summaries | 5 | 10% |
Disease patterns and progression | 2 | 4% |
Other research | 1 | 2% |
Laboratory research | 1 | 2% |
Agrawal R (2026). [PMID: 41365647](https://pubmed.ncbi.nlm.nih.gov/41365647/). *Journal of nuclear medicine technology*. [Case Report / Case Series]
Byun SH (2026). [PMID: 41364399](https://pubmed.ncbi.nlm.nih.gov/41364399/). *Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association*. [Epidemiology / Natural History]
You H (2026). [PMID: 42237425](https://pubmed.ncbi.nlm.nih.gov/42237425/). *Cancer Imaging*. [Diagnostic / Biomarker]
Hwang J (2026). [PMID: 41547694](https://pubmed.ncbi.nlm.nih.gov/41547694/). *Annals of surgical oncology*. [Review / Meta-Analysis]
Ruano-Balseca J (2026). [PMID: 41801777](https://pubmed.ncbi.nlm.nih.gov/41801777/). *IEEE Trans Med Imaging*. [Diagnostic / Biomarker]
Díaz Del Arco C (2026). [PMID: 42232601](https://pubmed.ncbi.nlm.nih.gov/42232601/). *Oncol Res*. [Diagnostic / Biomarker]
Sun Q (2026). [PMID: 41563935](https://pubmed.ncbi.nlm.nih.gov/41563935/). *Anticancer Drugs*. [Case Report / Case Series]
Lu HS (2026). [PMID: 41479338](https://pubmed.ncbi.nlm.nih.gov/41479338/). *Gut and liver*. [Clinical Trial Publication]
Endo S (2026). [PMID: 41563562](https://pubmed.ncbi.nlm.nih.gov/41563562/). *Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association*. [Diagnostic / Biomarker]
Hwang J (2026). [PMID: 41105369](https://pubmed.ncbi.nlm.nih.gov/41105369/). *Ann Surg Oncol*. [Clinical Trial Publication]